Title:
【発明の名称】イミダゾール誘導体およびRAFキナーゼ阻害剤としてのその使用
Document Type and Number:
Japanese Patent JP2003514906
Kind Code:
A
Abstract:
The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
Inventors:
David Kenneth Dean
Peter John Label
Andrew Kenneth Takul
Peter John Label
Andrew Kenneth Takul
Application Number:
JP2001540087A
Publication Date:
April 22, 2003
Filing Date:
November 20, 2000
Export Citation:
Assignee:
SmithKline Beechham Public Limited Company
International Classes:
A61K31/4439; A61K31/4545; A61K31/496; A61K31/506; A61K31/5377; A61P9/00; A61P9/10; A61P25/02; A61P25/28; A61P27/02; A61P35/00; A61P35/04; A61P43/00; C07D401/04; C07D401/14; C07D403/04; C07D405/14; C07D409/14; C07D413/14; C07D417/14; G06F9/46; G06F9/48; G06F13/24; (IPC1-7): C07D401/04; A61K31/4439; A61K31/4545; A61K31/496; A61K31/506; A61K31/5377; A61P25/02; A61P25/28; A61P35/00; A61P43/00; C07D401/14; C07D403/04; C07D405/14; C07D409/14; C07D417/14
Attorney, Agent or Firm:
Aoyama Ryo (2 outside people)